Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Gregorio Marañón, Madrid, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Madrid, Spain.
J Gen Physiol. 2023 Jan 2;155(1). doi: 10.1085/jgp.202112995. Epub 2022 Oct 26.
ATP-sensitive potassium (KATP) channels composed of Kir6.x and sulfonylurea receptor (SURs) subunits couple cellular metabolism to electrical activity. Cantú syndrome (CS) is a rare disease caused by mutations in the genes encoding Kir6.1 (KCNJ8) and SUR2A (ABCC9) that produce KATP channel hyperactivity due to a reduced channel block by physiological ATP concentrations. We functionally characterized the p.S1054Y SUR2A mutation identified in two CS carriers, who exhibited a mild phenotype although the mutation was predicted as highly pathogenic. We recorded macroscopic and single-channel currents in CHO and HEK-293 cells and measured the membrane expression of the channel subunits by biotinylation assays in HEK-293 cells. The mutation increased basal whole-cell current density and at the single-channel level, it augmented opening frequency, slope conductance, and open probability (Po), and promoted the appearance of multiple conductance levels. p.S1054Y also reduced Kir6.2 and SUR2A expression specifically at the membrane. Overexpression of ankyrin B (AnkB) prevented these gain- and loss-of-function effects, as well as the p.S1054Y-induced reduction of ATP inhibition of currents measured in inside-out macropatches. Yeast two-hybrid assays suggested that SUR2A WT and AnkB interact, while p.S1054Y interaction with AnkB is decreased. The p.E322K Kir6.2 mutation, which prevents AnkB binding to Kir6.2, produced similar biophysical alterations than p.S1054Y. Our results are the first demonstration of a CS mutation whose functional consequences involve the disruption of AnkB effects on KATP channels providing a novel mechanism by which CS mutations can reduce ATP block. Furthermore, they may help explain the mild phenotype associated with this mutation.
三磷酸腺苷敏感性钾 (KATP) 通道由 Kir6.x 和磺酰脲受体 (SUR) 亚基组成,将细胞代谢与电活动偶联。坎图综合征 (CS) 是一种罕见疾病,由编码 Kir6.1 (KCNJ8) 和 SUR2A (ABCC9) 的基因突变引起,由于生理 ATP 浓度降低对通道的阻断作用,导致 KATP 通道过度活跃。我们对在两名 CS 携带者中发现的 p.S1054Y SUR2A 突变进行了功能表征,尽管该突变被预测为高度致病性,但他们表现出轻度表型。我们在 CHO 和 HEK-293 细胞中记录了宏观和单通道电流,并通过 HEK-293 细胞中的生物素化测定测量了通道亚基的膜表达。该突变增加了基础全细胞电流密度,在单通道水平上,增加了开放频率、斜率电导和开放概率 (Po),并促进了多个电导水平的出现。p.S1054Y 还特异性地减少了 Kir6.2 和 SUR2A 在膜上的表达。锚蛋白 B (AnkB) 的过表达可防止这些增益和功能丧失效应,以及 p.S1054Y 诱导的在胞内剖片中测量的电流对 ATP 抑制的减少。酵母双杂交测定表明 SUR2A WT 和 AnkB 相互作用,而 p.S1054Y 与 AnkB 的相互作用减少。阻止 AnkB 与 Kir6.2 结合的 p.E322K Kir6.2 突变产生了与 p.S1054Y 相似的生物物理改变。我们的研究结果首次证明 CS 突变的功能后果涉及到 AnkB 对 KATP 通道的影响的破坏,为 CS 突变如何降低 ATP 阻断提供了一种新的机制。此外,它们可能有助于解释与该突变相关的轻度表型。